Study on Antiviral Therapy for HBeAg-positive Chronic Hepatitis B Patients Aged 1-16 Years
NCT04565262
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class
Conditions
HBeAg Positive Chronic Hepatitis B
Interventions
DRUG:
NAs+IFN-α
Sponsor
Beijing 302 Hospital